Post-Pandemic OHCA Survival Down; Vitamin D Supplements & BP; Varipulse PFA Approved Recent developments of interest in cardiovascular medicine Nov 12, 2024
Inching Toward a Blood Test for Hypertrophic Cardiomyopathy Researchers try to address challenge of distinguishing HCM from other cardiomyopathies Nov 11, 2024
Tricuspid Valve Replacement Finds Surer Footing With TRISCEND II's 1-Year Report Evoque device helped outcomes in severe tricuspid regurgitation, with some safety caveats Oct 31, 2024
Cold Weather Heart Attacks; Preemptive Valve Procedures Flop; Better Bleeding Score Recent developments of interest in cardiovascular medicine Oct 29, 2024
No Kidney Benefit With Finerenone in Heart Failure Patients Anti-mineralocorticoid agent reduced albuminuria, but not eGFR-based kidney outcome Oct 28, 2024
Major Win for Preemptive TAVR in Symptomless Aortic Stenosis Larger pool of TAVR candidates suggested by EARLY TAVR trial results Oct 28, 2024
Private Equity's Tighter Grip; ApoB Inhibitors vs Liver? Promising New RDN System Recent developments of interest in cardiovascular medicine Oct 22, 2024
COVID's Outsized Heart Risk; Prehab for Cardiac Surgery; Telerobotic Valve Repair Recent developments of interest in cardiovascular medicine Oct 15, 2024
Safety Data Favor Diuretic Strategy Triggered by Cardiac Monitoring Alerts in HF Effectiveness of this personalized approach now under investigation Oct 11, 2024
Elamipretide for Barth Syndrome Survives FDA Advisory Vote Panelists acknowledge difficulty generating stronger data in ultra-rare disease Oct 11, 2024
FDA Reviewers Cast Doubt on Drug Candidate for Barth Syndrome Agency appears unswayed by mitochondria-targeting drug for rare cardioskeletal disease Oct 09, 2024
Prime Locations for AEDs; Fluctuating Lp(a); Formalized Telestroke Training? Recent developments of interest in cardiovascular medicine Oct 08, 2024
Metabolic Accelerator Shows Promise for Weight Loss Side of Obesity-HFpEF Equation Benefit in symptoms, functional outcomes remains to be seen for HU6 Oct 02, 2024
VR Headsets in Cath Lab; ICDs & Driving Rules; How Cardiologist Got to Space Recent developments of interest in cardiovascular medicine Oct 01, 2024
Mavacamten Shows Promise in Heart Failure With Normal to Supranormal EF Cardiac myosin inhibitor linked to improvements in biomarkers in small study Sep 30, 2024
Case Strengthens for Cardiac Myosin Inhibitor in SEQUOIA-HCM Vast majority of trial participants responded to aficamten Sep 30, 2024
Does Finerenone's Efficacy Diminish if Initiated Late in Heart Failure? Benefit of the nonsteroidal MRA otherwise consistent across FINEARTS-HF Sep 29, 2024
Tragus Stimulation for High BP; House Passes HEARTS Act; Risk in Pregnancy Surrogacy Recent developments of interest in cardiovascular medicine Sep 24, 2024
Reconsider When a Prophylactic ICD Is Needed in Nonischemic Dilated Cardiomyopathy Meta-analysis holds LGE higher than LVEF in identifying high-risk NIDCM Sep 20, 2024
Lp(a) Cutoffs by Sex; LBBA Pacing Approvals; Loneliness Not to Blame for CVD? Recent developments of interest in cardiovascular medicine Sep 17, 2024
Are Regulators the Root of the Problem of Serious Device Recalls? Study lays out common gaps in evidence both before and after approval Sep 16, 2024
Defibrillator Positioning; PFA for PVC Ablation; Harvey Weinstein's Heart Surgery Recent developments of interest in cardiovascular medicine Sep 10, 2024
Oral Anticoagulation and TAVR Together: A Recipe for Trouble Continued OAC failed to meet noninferiority in POPular PAUSE TAVI Sep 03, 2024
TAVR's Win in Women; Chest Pressure During Cardioversion; Doc Goes to Space Recent developments of interest in cardiovascular medicine Sep 03, 2024
Nonsteroidal MRA Improves Outcomes in HFpEF, HFmrEF Randomized trial shows benefits beyond heart failure with low ejection fraction, but not survival Sep 01, 2024
Stenting, TAVR Make Sense Packaged Together for Some Patients NOTION-3 trial informs care for those with severe AS and stable CAD Sep 01, 2024
Another Trial Sides With MitraClip for Functional Mitral Regurgitation RESHAPE-HF2 has provocative implications for a wider pool of TEER candidates Aug 31, 2024
TriClip's 'Soft' Benefits Affirmed in Severe Tricuspid Regurgitation Randomized trial "highly encouraging" for making patients feel and function better Aug 31, 2024
Pause or Keep RAS Inhibitors Before Surgery? Take Your Pick. Either choice is "acceptable" based on randomized study Aug 31, 2024
Amyloidosis Drug Improves Outcomes, Survival RNA silencer impresses with results in transthyretin amyloidosis cardiomyopathy Aug 30, 2024
Clot Grabber IFU Recall; Free Cholesterol Tests at CVS; Naloxone for Cardiac Arrests Recent developments of interest in cardiovascular medicine Aug 27, 2024
Cardiologist’s Date Rape Verdict; Feds Come Down on DOAC Price; POC Test for HF? Recent developments of interest in cardiovascular medicine Aug 20, 2024
Bleeding Better Controlled When Protamine Is Part of TAVR Wrap-Up Routine ACE-PROTAVI trial tested upfront vs selective use of heparin reversal agent Aug 14, 2024
SGLT2 Hesitance; Furosemide's Indication Grows; Legal Fight Over Entresto Generic Recent developments of interest in cardiovascular medicine Aug 13, 2024
Sticky Patch Defibrillator; State Telehealth Laws and BP Meds; Ketones and HFpEF? Recent developments of interest in cardiovascular medicine Jul 30, 2024
Statin Candidate Pool Shrinks if PREVENT Risk Calculator Is Put to Current Practice Fewer people using primary prevention medications expected to result in more CVD Jul 29, 2024
Preeclampsia Blood Marker? Pediatric Cardiac Doc Arrested; Afib-Detecting Ring Recent developments of interest in cardiovascular medicine Jul 23, 2024
Pay People, and They Will Go to Cardiac Rehab Financial rewards increase participation in guideline-recommended programs Jul 22, 2024
D.C. Hospital Gets a Wake-Up Call to Chagas Disease Report is part of larger efforts to increase awareness of neglected disease Jul 17, 2024
Industry $$ for New Cardiologists; Strokes After Falls; Self-Cleaning TAVR Valve? Recent developments of interest in cardiovascular medicine Jul 16, 2024
